New division portfolio 2025

New Division portfolio FAQ

• What is the new Division portfolio?
• Why is the transition happening?
• When will the transition take place?
• How will the transition affect me and my Division?
• What will happen with my old Division memberships?
• What are the transition scenarios?
• How can I change my Division membership options/subscriptions?
• Can I be a member of multiple Divisions?
• What changes to Division membership fees can members expect as part of the transition?
• What support will be provided during the transition?
• How will the transition impact the Artery, ADLM's online member community?
• How will the Divisions’ events at the ADLM Annual Meeting be impacted?
• What leadership opportunities will the new Divisions offer?
• When will the new Divisions hold elections?
• How can I participate in the officer board of my Division?
• What support will be provided during the transition?
• What was the process behind the Division restructuring project?
• Where can I find more information?
• Who can I contact for more information or assistance?

What is the new Division portfolio?

For more than 40 years, ADLM (formerly AACC) has maintained a strong Divisions program, fostering scientific achievements among its members. However, in recent years, engagement within the Divisions has declined. To ensure alignment with current advancements in the field and to prepare for the future of healthcare and laboratory medicine, ADLM's board of directors initiated a review of the Divisions program. ADLM is proud to announce that, thanks to a dedicated task force, we are implementing a revised portfolio that reflects the current landscape of lab medicine. This restructure maintains the program's valuable features such as awards, advancement opportunities, and networking. Additionally, it introduces clear pathways of value for early-career, mid-career, and established professionals, encouraging growth and giving back to the community.

Review a list of the new Divisions and their descriptions.

Review a schematic of the new governance terms.

Why is the transition happening?

To better align with the changing dynamics of the laboratory and diagnostics field, ADLM is restructuring the Divisions program. This restructuring aims to align the Divisions with current lab practice areas, ensuring they remain relevant and valuable to members.

When will the transition take place?

January 2025

Transition timeline:

• May 2024 – Initial information on the new portfolio available on ADLM’s website
• July 2024 – Opening plenary & opening mixer at ADLM ’24 will provide a sneak peek into the new portfolio
• August 2024 – New appointed Division officers announced
• September 2024 – Membership renewal for Divisions will feature new Divisions
• October 2024 – Member Q&A session
• January 2025 – New portfolio launched
• April 2025 – Old Division portfolio fully retired
• July 2025 – New Division portfolio featured at ADLM ‘25

How will the transition affect me and my Division?

The streamlined Division portfolio will enhance the scope of practice, broaden leadership opportunities, and increase volunteer participation. We are introducing new governance and leadership roles, aimed at promoting more active Division boards with engaged members from all areas of our membership.

What will happen with my old Division memberships?

To make the transition as easy as possible for members, now that the new Division portfolio has launched, your old Division memberships have been automatically transferred to the new Divisions that best match the Divisions that you were previously a part of.

What are the Division transition scenarios?

• One-to-One Transition: In this scenario, existing Divisions have transitioned directly to a new Division with the same ID under the revised portfolio. The focus, scope, and practice areas of the Division will remain largely the same. The transition will involve updating the Division's logo, scope of practice description, and adjusting its governance structure to align with the new standards set for all Divisions. Members of one-to-one transitions will automatically become members of the new Division, maintaining their existing involvement and benefits within the revised program.
  • Divisions that fall within this transition type:
    • Health Equity & Access Division (HEA)
    • Hematology & Coagulation Division (HEMCOAG)
    • Pediatric & Maternal-Fetal Division (PMF)
    • Therapeutic Drug Management & Toxicology Division (TDMTOX)
      
      
• New ID but One-to-One Transition: Under this scenario, Divisions have undergone an ID change, but the scope and practice areas of these Divisions will remain largely unchanged. The transition will involve updating the Division's logo, scope of practice description, and adjusting its governance structure to align with the new standards set for all Divisions. Members of these transitions will automatically become members of the new Division, maintaining their existing involvement and benefits within the revised program.
  • Divisions that fall within this transition type:
    • Informatics Division -> Data Science & Informatics Division (DSI)
    • Critical & Point-of-Care Testing Division (CPOCT) -> Point-of-Care Testing Division (POCT)
    • Management Sciences and Patient Safety Division (MSPS) -> Stewardship & Management Sciences Division (SPM)

• Merging Multiple Divisions into One New Division: This scenario involves the merger of several existing Divisions into a single new Division under the revised portfolio. The process of merging Divisions can be complex, as it requires aligning the focus, goals, and governance structures of the merging Divisions into a cohesive new entity. The Division Program Implementation Task Force worked closely with Division leaders to identify commonalities and areas of overlap. A new, comprehensive scope and practice area for the merged Division that incorporates the strengths of each original Division was developed. The goal of the revised governance structures is to provide consistency across all Divisions and to accommodate the larger size and increased diversity of the merged Division, ensuring fair representation for all members. The Division Program Implementation Task Force worked with leaders of the old Divisions to establish leadership roles and opportunities for member involvement within the merged Division.
  • Current members of merged Divisions will be automatically moved to new, merged Divisions with overlapping interests for the first year.  
  • Divisions that fall within this transition type:
    • Tumor Markers and Cancer Diagnostics Division, Molecular Pathology Division, Clinical Translational Sciences Division, Personalized Medicine Division -> Cancer Diagnostics & Monitoring Division (CDM)
    • Biomarkers of Acute Cardiovascular Disease Division, Lipoproteins and Vascular Diseases Division, Nutrition Division, Clinical Translational Sciences Division -> Cardiovascular Health Division (CVH)
    • Endocrinology Division, Clinical Translational Sciences Division, Nutrition Division -> Endocrinology & Metabolism Division (ENDOMET)
    • Personalized Medicine Division, Molecular Pathology Division -> Genetics & Genomics Division (G&G)
    • Industry Division, Clinical Translational Sciences Division, Proteomics & Metabolomics Division, Mass Spectrometry Division, Nutrition Division -> Innovation & Technology Division (INT)
    • Clinical & Diagnostic Immunology Division, Clinical Translational Sciences Division -> Immunology & Infectious Disease Division (IID)

• Reorganization:
  • The History Division has been reorganized as a Special Committee reporting to the board of directors secretary for the advancement of special projects (more information forthcoming).
  • The Animal Clinical Chemistry Division has also been reorganized as the Comparative Laboratory Medicine Special Interest Group (more information forthcoming).
  • A History Artery forum and Comparative Laboratory Medicine Artery forum will be maintained to encourage discussion of topics related to the history of clinical chemistry, animal clinical chemistry, the association, etc.

How can I change my Division membership options/subscriptions?

• You can easily change your Division memberships until February 28, 2025. You can do so by contacting ADLM’s Customer Service at [email protected] or 1.800.892.1400.
• And don’t worry if you miss the February 28 deadline — you can always make changes whenever your membership is up for renewal again.

Can I be a member of multiple Divisions?

• Yes, you can join multiple Divisions. Please feel free to contact ADLM’s customer service at [email protected] or 1.800.892.1400 if you wish to do so.

What changes to Division membership fees can members expect as part of the transition?

• Pricing will remain at $25/division in 2025.
• The board of directors will evaluate and may elect to increase fees in subsequent years.

What support will be provided during the transition?

• The Division Program Implementation Task Force and the Science & Practice Core Committee (SPCC) will provide member-based support during the Divisions transition. If you have a question for either of these groups, please contact ADLM's Manager of Divisions ([email protected]).
• ADLM staff can be contacted for any additional questions.

How will the transition impact the Artery, ADLM’s online member community?

• New Artery platforms have been created, and the old Division platforms have been archived (available as reference for all Division members). To view the new Division Artery communities, go to the Artery and click on the "Divisions" dropdown in the top navigation.
• When joining one of the new Divisions, you will still have access to all of the Artery forums for Divisions that are a part of the program. In addition, you will have access to the previous retired Divisions' Artery pages that have been archived.

How will the Divisions’ events at the ADLM Annual Meeting be impacted?

• Every Division in the new portfolio will be hosting an event during ADLM 2025, which is taking place in Chicago in late July of 2025. The meeting’s Opening Plenary Mixer will also feature the Divisions.
• Division events at ADLM 2025 will be announced on each Division’s Artery forum and via regular communications about the Annual Meeting.

What leadership opportunities will the new Divisions offer?

A major goal for ADLM’s new Division portfolio is to broaden leadership opportunities — particularly for early-career laboratory medicine professionals — and to increase volunteer participation. To that end, the new Divisions feature new, well-defined leadership roles aimed at promoting more active Division boards with engaged members from all areas of ADLM’s membership. This will especially benefit professionals who are just starting out in the field, as serving in these roles will give them incredibly valuable leadership experience that will help them to advance their careers.

Review a list of the new leadership roles and their descriptions.

Review a schematic of the new governance terms.

When will the new Divisions hold elections?

• The new Divisions have launched with a set roster of officers drawn from the leadership and membership of the old Divisions.
• Starting in 2026, elections for core officer roles will take place every spring. Division members will have the opportunity to nominate individuals for core officer roles from February-March, and the elections themselves will happen in May-June. Elected officers will serve a set term that will start on August 1 following the election.
• Supporting officer roles, on the other hand, will be appointed by core officers and will not be elected.
• Some new Divisions might hold elections in the spring of 2025, but this is still to be determined. So keep an eye out for more information on this from Division leadership in the coming months.

How can I participate in the officer board of my Division?

If you’d like to participate in your Division by taking on a supporting officer role, please don’t hesitate to reach out. You can contact your Division’s core officers directly or via your Division’s new Artery page. ADLM’s Division program is member-led and the officers are always looking out for members who would like to get involved.

What was the process behind the Division restructuring project?

1. Formation of the Division Program Implementation Task Force and Key Dates: In March 2022, the ADLM board of directors established the Division Program Review Task Force (DPRTF) to assess the current Division program and portfolio. The DPRTF presented initial recommendations revising the Division structure in July 2022. The board of directors approved the recommendations and transitioned the DPRTF to the Division Program Implementation Task Force (DPITF) to operationalize the plan. Both task forces were composed of current or past Division chairs: Alison Woodworth, PhD (Chair), Jennifer Colby, PhD, Stanley Lo, PhD, Stacy Melanson, MD, PhD, and Octavia Peck Palmer, PhD.
2. Board of Directors Directives: The board of directors directed the Division Program Implementation Task Force to assess the current Division program and portfolio and make recommendations for its restructuring.
3. Meetings with SPCC and Divisions: The Division Program Implementation Task Force engaged with the Science & Practice Core Committee and Division leadership to gather input and feedback on the proposed Division restructuring.
4. Criteria for Restructuring:
   • Membership Analysis: The Division Program Implementation Task Force conducted a thorough analysis of current membership numbers in each Division. They looked at areas where members overlapped between Divisions or where there were topical gaps, as well as which Divisions had high percentages of unique members. This analysis helped ensure that the new Division structure would better meet the needs of all members.
   • Engagement and Value Assessment: The task force reviewed the annual reports of all current Divisions for the past several years to assess their level of engagement and value to members. This information was crucial in identifying areas where Divisions could be enhanced or where new Divisions were needed to better serve the membership.
   • Best Practices Benchmarking: The Division Program Implementation Task Force studied how similar healthcare associations and organizations structured their thematic structures for membership. This benchmarking helped ensure that ADLM's new Division structure aligned with industry best practices and would be effective in meeting the needs of ADLM members and the association.
   • Current Practice Areas Assessment: The task force also assessed the current practice areas within laboratory medicine, diagnostics, and adjacent fields to ensure that the new Divisions reflected the current state of the field. This ensured that the new structure would be relevant and responsive to the evolving needs of the profession.
5. Consultation Process: The Division Program Implementation Task Force consulted with the SPCC and Division leadership through surveys, meetings, and one-on-one discussions to gather feedback on the proposed restructuring.
6. Communication Plan: The Division Program Implementation Task Force developed a communication plan to socialize the proposed changes with Division leadership and gather feedback for a successful transition.
7. Core Officer Selections: In lieu of normal Division leadership elections during this transition period, the Division Program Implementation Task Force worked with current Division leaders to identify the six core officers for each new Division. The task force made final recommendations for this core group to take up the new Division starting in August 2024.
8. Supporting Officer Selections: Once the core officer board was in place, the Division Program Implementation Task Force supported them in identifying five individuals to complete the supporting officer selections. The goal of this was for each Division to have a full, working board by January 2025.

Where can I find more information?

• In the November 2024 episode of ADLM’s Laborastories podcast, Division Task Force member Octavia Peck Palmer, PhD, discussed how ADLM’s Divisions advance clinical laboratory testing and patient care, how members can join them, and how the new Division structure will better align with both the current and future practice of laboratory medicine. Listen to the podcast.
• In December 2024, ADLM CEO Mark J. Golden posted on the Artery about why and how ADLM went about restructuring the Divisions — and how this change will benefit you, our members, as well as the profession. Read the blog post.
• Later this January, ADLM President Anthony Killeen, MD, PhD, will also hold an Ask Me Anything (AMA) session on the Artery about the Division transition. More information about this upcoming AMA will be communicated with members via the Artery, email, and through the ADLM website.

Who can I contact for more information or assistance?

Please contact ADLM's Manager of Divisions ([email protected]).